Latest News

GeoVax to Present its MVA Vector Platform Technology at Vaccinology Conference
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today ...
Continue Reading...
GeoVax Awarded NIH Fast Track Phase I/II Grant to Advance Lassa Fever Vaccine
Deadly epidemic continues in Nigeria; Lassa virus remains endemic in West Africa GeoVax Labs, Inc. ...
Continue Reading...
GeoVax Recognized as “Best Biotech” at Vaccine Industry Excellence Awards during World Vaccine Congress
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, is honored to an...
Continue Reading...